US Patent Issued to Duke University, Ohio State Innovation Foundation on Jan. 13 for "Nanoparticle systems for targeted delivery of CRISPR/Cas13 and methods of using same" (North Carolina, Ohio Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,355, issued on Jan. 13, was assigned to Duke University (Durham, N.C.) and Ohio State Innovation Foundation (Columbus, Ohio).

"Nanoparticle systems for targeted delivery of CRISPR/Cas13 and methods of using same" was invented by Qianben Wang (Durham, N.C.), Zhifen Cui (Durham, N.C.) and Yizhou Dong (Columbus, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to nanoparticles for the targeted delivery of CRISPR/Cas13 systems, and their therapeutic use to treat diseases and disorders such as prostate cancer and COVID-19."

The patent was filed on July 13, 2020, under Application No. 17/626,482.

*For further informati...